138 related articles for article (PubMed ID: 8631798)
1. Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library.
de Kruif J; Logtenberg T
J Biol Chem; 1996 Mar; 271(13):7630-4. PubMed ID: 8631798
[TBL] [Abstract][Full Text] [Related]
2. Formation of a bispecific antibody by the use of leucine zippers.
Kostelny SA; Cole MS; Tso JY
J Immunol; 1992 Mar; 148(5):1547-53. PubMed ID: 1531669
[TBL] [Abstract][Full Text] [Related]
3. Toward the production of bispecific antibody fragments for clinical applications.
Carter P; Ridgway J; Zhu Z
J Hematother; 1995 Oct; 4(5):463-70. PubMed ID: 8581386
[TBL] [Abstract][Full Text] [Related]
4. Bivalent antibody phage display mimics natural immunoglobulin.
Lee CV; Sidhu SS; Fuh G
J Immunol Methods; 2004 Jan; 284(1-2):119-32. PubMed ID: 14736422
[TBL] [Abstract][Full Text] [Related]
5. Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments.
Fagète S; Botas-Perez L; Rossito-Borlat I; Adea K; Gueneau F; Ravn U; Rousseau F; Kosco-Vilbois M; Fischer N; Hartley O
Protein Eng Des Sel; 2017 Sep; 30(9):575-582. PubMed ID: 28444391
[TBL] [Abstract][Full Text] [Related]
6. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
Sellers JW; Struhl K
Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
[TBL] [Abstract][Full Text] [Related]
7. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
[TBL] [Abstract][Full Text] [Related]
8. Construction, purification, and characterization of a hybrid protein comprising the DNA binding domain of the LexA repressor and the Jun leucine zipper: a circular dichroism and mutagenesis study.
Schmidt-Dörr T; Oertel-Buchheit P; Pernelle C; Bracco L; Schnarr M; Granger-Schnarr M
Biochemistry; 1991 Oct; 30(40):9657-64. PubMed ID: 1911752
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
Leonard DA; Rajaram N; Kerppola TK
Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
[TBL] [Abstract][Full Text] [Related]
10. Preferential heterodimer formation by isolated leucine zippers from fos and jun.
O'Shea EK; Rutkowski R; Stafford WF; Kim PS
Science; 1989 Aug; 245(4918):646-8. PubMed ID: 2503872
[TBL] [Abstract][Full Text] [Related]
11. A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain.
Schoonjans R; Willems A; Schoonooghe S; Leoen J; Grooten J; Mertens N
Biomol Eng; 2001 Jun; 17(6):193-202. PubMed ID: 11337278
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.
Weber-Bornhauser S; Eggenberger J; Jelesarov I; Bernard A; Berger C; Bosshard HR
Biochemistry; 1998 Sep; 37(37):13011-20. PubMed ID: 9737882
[TBL] [Abstract][Full Text] [Related]
13. The leucine zippers of c-fos and c-jun for progesterone receptor dimerization: A-dominance in the A/B heterodimer.
Mohamed MK; Tung L; Takimoto GS; Horwitz KB
J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):241-50. PubMed ID: 7826885
[TBL] [Abstract][Full Text] [Related]
14. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
Cohen DR; Curran T
Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
[TBL] [Abstract][Full Text] [Related]
15. Preparation of a bispecific F(ab')2 targeted to the human IL-2 receptor.
Tso JY; Wang SL; Levin W; Hakimi J
J Hematother; 1995 Oct; 4(5):389-94. PubMed ID: 8581374
[TBL] [Abstract][Full Text] [Related]
16. A novel variable antibody fragment dimerized by leucine zippers with enhanced neutralizing potency against rabies virus G protein compared to its corresponding single-chain variable antibody fragment.
Li Z; Cheng Y; Xi H; Gu T; Yuan R; Chen X; Jiang C; Kong W; Wu Y
Mol Immunol; 2015 Dec; 68(2 Pt A):168-75. PubMed ID: 26325475
[TBL] [Abstract][Full Text] [Related]
17. Construction, expression, and activity of a bivalent bispecific single-chain antibody.
Mallender WD; Voss EW
J Biol Chem; 1994 Jan; 269(1):199-206. PubMed ID: 8276795
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
19. Cloning, expression, and spectroscopic studies of the Jun leucine zipper domain.
Riley LG; Junius FK; Swanton MK; Vesper NA; Williams NK; King GF; Weiss AS
Eur J Biochem; 1994 Feb; 219(3):877-86. PubMed ID: 8112339
[TBL] [Abstract][Full Text] [Related]
20. DNA binding and transactivation properties of Fos variants with homodimerization capacity.
Porte D; Oertel-Buchheit P; John M; Granger-Schnarr M; Schnarr M
Nucleic Acids Res; 1997 Aug; 25(15):3026-33. PubMed ID: 9304112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
